The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease

Bibliography

• Belloni L, Pollicino T, De Nicola F, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci USA 2009;106:19975-9
   PubMed Web of Science ®Google Scholar
• Summers J, Mason WS. Replication of the genome of a hepatitis B–like virus by reverse transcription of an RNA intermediate. Cell 1982;29:403-15
   PubMed Web of Science ®Google Scholar
• Keasler VV, Hodgson AJ, Madden CR, Slagle BL. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 2007;81:2656-62
   PubMed Web of Science ®Google Scholar
• Feitelson MA, Reis HM, Tufan NL, et al. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease. Cancer Lett 2009;286:69-79
   Google Scholar
• Colgrove R, Simon G, Ganem D. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol 1989;63:4019-26
   PubMed Web of Science ®Google Scholar
• Chen HS, Kaneko S, Girones R, et al. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 1993;67:1218-26
   PubMedGoogle Scholar
• Reifenberg K, Wilts H, Löhler J, et al. The hepatitis B virus X protein transactivates viral core gene expression in vivo. J Virol 1999;73:10399-405
   PubMed Web of Science ®Google Scholar
• Lucifora J, Arzberger S, Durantel D, et al. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol 2011;55:996-1003
   PubMed Web of Science ®Google Scholar
• Benhenda S, Cougot D, Buendia M-A, Neuveut C. Hepatitis B virus X protein: molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 2009;103:75-109
   Google Scholar
• Hu Z, Zhang Z, Doo E, et al. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol 1999;73:7231-40
   PubMed Web of Science ®Google Scholar
• Zhang Z, Protzer U, Hu Z, et al. Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J Virol 2004;78:4566-72
   PubMed Web of Science ®Google Scholar
• Sohn SY, Kim SB, Kim J, Ahn BY. Negative regulation of hepatitis B virus replication by cellular Hsp40/DnaJ proteins through destabilization of viral core and X proteins. J Gen Virol 2006;87:1883-91
   PubMed Web of Science ®Google Scholar
• Shin GC, Ahn SH, Choi HS, et al. Hepatocystin/80K-H inhibits replication of hepatitis B virus through interaction with HBx protein in hepatoma cell. Biochim Biophys Acta 2013;1832:1569-81
   PubMed Web of Science ®Google Scholar
• Leupin O, Bontron S, Schaeffer C, Strubin M. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol 2005;79:4238-45
   PubMed Web of Science ®Google Scholar
• Sitterlin D, Bergametti F, Tiollais P, et al. Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses. Oncogene 2000;19:4427-31
   PubMedGoogle Scholar
• Gong DY, Chen EQ, Huang FJ, et al. Role and functional domain of hepatitis B virus X protein in regulating HBV transcription and replication in vitro and in vivo. Viruses 2013;5:1261-71
   PubMed Web of Science ®Google Scholar
• Luo L, Chen S, Gong Q, et al. Hepatitis B virus X protein modulates remodeling of minichromosomes related to hepatitis B virus replication in HepG2 cells. Int J Mol Med 2013;31:197-204
   Google Scholar
• Benhenda S, Ducroux A, Rivière L, et al. Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription. J Virol 2013;87:4360-71
   PubMed Web of Science ®Google Scholar
• Tang H, Delgermaa L, Huang F, et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 2005;79:5548-56
   Google Scholar
• Sir D, Tian Y, Chen WL, et al. The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication. Proc Natl Acad Sci USA 2010;107:4383-8
   PubMed Web of Science ®Google Scholar
• Mao Y, Da L, Tang H, et al. Hepatitis B virus X protein reduces starvation-induced cell death through activation of autophagy and inhibition of mitochondrial apoptotic pathway. Biochem Biophys Res Commun 2011;415(1):68-74
   PubMed Web of Science ®Google Scholar
• Li B, Gao B, Ye L, et al. Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response. Virus Res 2007;124:44-9
   PubMed Web of Science ®Google Scholar
• Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 2001;294:2376-8
   PubMed Web of Science ®Google Scholar
• Klein NP, Bouchard MJ, Wang LH, et al. Src kinases involved in hepatitis B virus replication. EMBO J 1999;18:5019-27
   PubMedGoogle Scholar
• Rahmani Z, Huh KW, Lasher R, Siddiqui A. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 2000;74:2840-6
   PubMed Web of Science ®Google Scholar
• McClain SL, Clippinger AJ, Lizzano R, Bouchard MJ. Hepatitis B virus replication is associated with an HBx-dependent mitochondrion-regulated increase in cytosolic calcium levels. J Virol 2007;81:12061-5
   Google Scholar
• Jin YM, Yun C, Park C, et al. Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases. J Viral Hepat 2001;8(5):322-30
   PubMed Web of Science ®Google Scholar
• Wang WL, London WT, Lega L, Feitelson MA. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 1991;14:29-37
   Google Scholar
• Ohno H, Kaneko S, Kobayashi K, Murakami S. Human hepatitis B virus enhancer 1 is responsive to human interleukin-6. J Med Virol 1997;52:413-18
   Google Scholar
• Shukla R, Yue J, Siouda M, et al. Proinflammatory cytokine TNF-alpha increases the stability of hepatitis B virus X protein through NF-kappaB signaling. Carcinogenesis 2011;32:978-85
   PubMedGoogle Scholar
• Lara-Pezzi E, Majano PL, Gómez-Gonzalo M, et al. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology 1998;28:1013-21
   PubMed Web of Science ®Google Scholar
• Meyer M, Caselmann WH, Schlüter V, et al. Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J 1992;11:2991-3001
   PubMed Web of Science ®Google Scholar
• Pan J, Lian Z, Wallett S, Feitelson MA. The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin. J Gen Virol 2007;88:3275-85
   Google Scholar
• Pan J, Duan LX, Sun BS, Feitelson MA. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappaB. J Gen Virol 2001;82:171-82
   PubMed Web of Science ®Google Scholar
• Kim JY, Song EH, Lee HJ, et al. HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways. J Mol Biol 2010;397:917-31
   Google Scholar
• Kim KH, Shin HJ, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 2007;132:1955-67
   PubMed Web of Science ®Google Scholar
• Yoo YD, Ueda H, Park K, et al. Regulation of transforming growth factor-beta1 expression by the hepatitis B virus (HBV) X transactivator. J Clin Invest 1996;97:388-95
   PubMed Web of Science ®Google Scholar
• Norton PA, Reis HM, Prince S, et al. Activation of fibronectin gene expression by hepatitis B virus x antigen. J Viral Hepat 2004;11:332-41
   PubMed Web of Science ®Google Scholar
• Lee DK, Park SH, Yi Y, et al. The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 2001;15:455-66
   PubMed Web of Science ®Google Scholar
• Shih WL, Kuo ML, Chuang SE, et al. Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase. J Biol Chem 2003;278:31807-13
   PubMed Web of Science ®Google Scholar
• Murata M, Matsuzaki K, Yoshida K, et al. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology 2009;49:1203-17
   Google Scholar
• Guo GH, Tan DM, Zhu PA, Liu F. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2. Hepatobiliary Pancreat Dis Int 2009;8:59-64
   PubMed Web of Science ®Google Scholar
• Martín-Vílchez S, Sanz-Cameno P, Rodríguez-Muñoz Y, et al. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 2008;47:1872-83
   PubMedGoogle Scholar
• Han YP. Matrix metalloproteinases, the pros and cons, in liver fibrosis. J Gastroenterol Hepatol 2006;21:S88-91
   Google Scholar
• Zeisberg M, Yang C, Martino M, et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007;282:23337-47
   PubMed Web of Science ®Google Scholar
• Yang SZ, Zhang AQ, Chen G, et al. Experimental study of epithelial-mesenchymal transition induced by HBx protein in liver cancer cell. Zhonghua Yi Xue Za Zhi 2010;90:818-21
   Google Scholar
• Arzumanyan A, Friedman T, Kotei E, et al. Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene 2012;31:563-72
   PubMedGoogle Scholar
• Lee JO, Kwun HJ, Jung JK, et al. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 2005;24:6617-25
   PubMedGoogle Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31
   PubMed Web of Science ®Google Scholar
• Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2001;2:667-73
   PubMed Web of Science ®Google Scholar
• Yoo YG, Na TY, Seo HW, et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008;27:3405-13
   PubMed Web of Science ®Google Scholar
• Lee SW, Lee YM, Bae SK, et al. Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem Biophys Res Commun 2000;268:456-61
   PubMed Web of Science ®Google Scholar
• Yoo YG, Oh SH, Park ES, et al. Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. J Biol Chem 2003;278:39076-84
   PubMed Web of Science ®Google Scholar
• Sanz-Cameno P, Martín-Vílchez S, Lara-Pezzi E, et al. Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein. Am J Pathol 2006;169:1215-22
   PubMedGoogle Scholar
• Shen L, Zhang X, Hu D, et al. Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt/beta-catenin pathway. Mol Cell Biochem 2013; In press
   Google Scholar
• Huang J, Shen L, Lu Y, et al. Parallel induction of cell proliferation and inhibition of cell differentiation in hepatic progenitor cells by hepatitis B virus X gene. Int J Mol Med 2012;30:842-8
   Google Scholar
• Lu Y, Shen L, Li H, et al. HBx induction of epithelial mesenchymal transition in mouse hepatic progenitor cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2013;29:146-9
   Google Scholar
• Yang SZ, Zhang LD, Zhang Y, et al. HBx protein induces EMT through c-Src activation in SMMC-7721 hepatoma cell line. Biochem Biophys Res Commun 2009;382:555-60
   Google Scholar
• Lara-Pezzi E, Roche S, Andrisani OM, et al. The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner. Oncogene 2001;20:3323-31
   PubMed Web of Science ®Google Scholar
• Arzumanyan A, Friedman T, Ng IO, et al. Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res 2011;71:3701-8
   PubMed Web of Science ®Google Scholar
• Wei C, Ni C, Song T, et al. The hepatitis B virus X protein disrupts innate immunity by down-regulating mitochondrial antiviral signaling protein. J Immunol 2010;185:1158-68
   PubMed Web of Science ®Google Scholar
• Jiang J, Tang H. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein. Protein Cell 2010;1:1106-17
   PubMed Web of Science ®Google Scholar
• Xia L, Tian D, Huang W, et al. Up-regulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-kappaB pathway. J Immunol 2012;188:753-64
   Web of Science ®Google Scholar
• Yue X, Yang F, Yang Y, et al. Induction of cyclooxygenase-2 expression by hepatitis B virus depends on demethylation-associated recruitment of transcription factors to the promoter. Virol J 2011;8:118
   PubMedGoogle Scholar
• Pan X, Cao H, Lu J, et al. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-kappaB. Mol Immunol 2011;48:1573-7
   PubMed Web of Science ®Google Scholar
• Lee MO, Choi YH, Shin EC, et al. Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection. J Hepatol 2002;37:380-6
   PubMedGoogle Scholar
• Kuo CY, Tsai JI, Chou TY, et al. Apoptosis induced by hepatitis B virus X protein in a CCL13-HBx stable cell line. Oncol Rep 2012;28:127-32
   PubMed Web of Science ®Google Scholar
• Diao J, Khine AA, Sarangi F, et al. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J Biol Chem 2001;276:8328-40
   PubMed Web of Science ®Google Scholar
• Gottlob K, Fulco M, Levrero M, Graessmann A. The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem 1998;273:33347-53
   PubMed Web of Science ®Google Scholar
• Shih WL, Kuo ML, Chuang SE, et al. Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem 2000;275:25858-64
   PubMed Web of Science ®Google Scholar
• Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 2001;21:7721-30
   PubMed Web of Science ®Google Scholar
• Liu H, Yuan Y, Guo H, et al. Hepatitis B virus encoded X protein suppresses apoptosis by inhibition of the caspase-independent pathway. J Proteome Res 2012;11:4803-13
   PubMedGoogle Scholar
• Tang H, Da L, Mao Y, et al. Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology 2009;49:60-71
   PubMed Web of Science ®Google Scholar
• Clippinger AJ, Gearhart TL, Bouchard MJ. Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappaB and the mitochondrial permeability transition pore. J Virol 2009;83:4718-31
   PubMed Web of Science ®Google Scholar
• Shintani Y, Yotsuyanagi H, Moriya K, et al. Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system. J Gen Virol 1999;80:3257-65
   PubMed Web of Science ®Google Scholar
• Pollicino T, Terradillos O, Lecoeur H, et al. Pro-apoptotic effect of the hepatitis B virus X gene. Biomed Pharmacother 1998;52:363-8
   PubMed Web of Science ®Google Scholar
• Chirillo P, Pagano S, Natoli G, et al. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA 1997;94:8162-7
   PubMed Web of Science ®Google Scholar
• Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem 1998;273:381-5
   PubMed Web of Science ®Google Scholar
• Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1997;94:8744-9
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim SY, Kim J, et al. Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria. IUBMB Life 2008;60:473-80
   PubMed Web of Science ®Google Scholar
• Kuo CY, Wang JC, Wu CC, et al. Effects of hepatitis B virus X protein (HBx) on cell-growth inhibition in a CCL13-HBx stable cell line. Intervirology 2008;51:26-32
   Google Scholar
• Terradillos O, de La Coste A, Pollicino T, et al. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. Oncogene 2002;21:377-86
   PubMedGoogle Scholar
• Tralhao JG, Roudier J, Morosan S, et al. Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci USA 2002;99:6991-6
   Google Scholar
• Pan J, Clayton MM, Feitelson MA. HBxAg promotes transforming growth factor beta1 (TGFbeta1) activity by up-regulation of TGFβ1 and down-regulation of alpha 2-macroglobulin. J Gen Virol 2004;85:275-82
   PubMedGoogle Scholar
• Qiao L, Leach K, McKinstry R, et al. Hepatitis B virus X protein increases expression of p21Cip-1/WAF1/MDA6 and p27Kip-1 in primary mouse hepatocytes, leading to reduced cell cycle progression. Hepatology 2001;34:906-17
   Google Scholar
• Park ES, Park YK, Shin CY, et al. Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase-type plasminogen activator. Hepatology 2013;58:762-76
   PubMed Web of Science ®Google Scholar
• Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-33
   PubMed Web of Science ®Google Scholar
• Snyder RL, Tyler G, Summers J. Chronic hepatitis and hepatocellular carcinoma associated with WHV. Am J Pathol 1982;107:422-5
   Google Scholar
• Popper H, Roth L, Purcell RH, et al. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 1987;84:866-70
   PubMed Web of Science ®Google Scholar
• Wollersheim M, Debelka U, Hofschneider PH. A trans-activating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 1988;3:545-52
   PubMedGoogle Scholar
• Diamantis ID, McGandy CE, Chen TJ, et al. Hepatitis B X-gene expression in hepatocellar carcinoma. J Hepatol 1992;15:400-3
   Google Scholar
• Dandri M, Schirmacher P, Rogler CE. WHV X protein is present in chronically infected woodchuck liver and woodchuck HCCs which are permissive for viral replication. J Virol 1996;70:5246-54
   PubMedGoogle Scholar
• Hohne M, Schaefer S, Seifer M, et al. Malignant transformation of immortalized hepatocytes by HBV DNA. EMBO J 1990;9:1137-45
   PubMed Web of Science ®Google Scholar
• Kim CM, Koike K, Saito I, et al. HBx gene of HBV induces liver cancer in transgenic mice. Nature 1991;351:317-20
   PubMed Web of Science ®Google Scholar
• Henkler F, Koshy R. Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis. J Viral Hepat 1996;3:109-21
   Google Scholar
• Huang J, Kwong J, Sun ECY, Liang TJ. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol 1996;70:5582-91
   PubMed Web of Science ®Google Scholar
• Tian Y, Yang W, Song J, et al. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol 2013;33:2810-16
   PubMed Web of Science ®Google Scholar
• Park IY, Sohn BH, Yu E, et al. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 2007;132:1476-94
   PubMed Web of Science ®Google Scholar
• Zhu YZ, Zhu R, Fan J, et al. Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis. J Viral Hepat 2010;17:98-107
   PubMedGoogle Scholar
• Zheng DL, Zhang L, Cheng N, et al. Epigenetic modification induced by hepatitis B virus X protein via interaction with de novoDNAmethyltransferase DNMT3A. J Hepatol 2009;50:377-87
   PubMedGoogle Scholar
• Pollicino T, Bellinghieri L, Restuccia A, et al. Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. Virology 2013;444:317-28
   Google Scholar
• Cougot D, Wu Y, Cairo S, et al. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J Biol Chem 2007;282:4277-87
   PubMed Web of Science ®Google Scholar
• Hamamoto R, Silva FP, Tsuge M, et al. Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci 2006;97:113-18
   PubMed Web of Science ®Google Scholar
• Yang L, He J, Chen L, Wang G. Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells. Med Oncol 2009;26:445-51
   PubMed Web of Science ®Google Scholar
• Tang H, Oishi N, Kaneko S, Murakami S. Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci 2006;97:977-83
   PubMed Web of Science ®Google Scholar
• Henkler F, Hoare J, Waseem N, et al. Intracellular localization of the hepatitis B virus HBx protein. J Gen Virol 2001;82:871-82
   PubMed Web of Science ®Google Scholar
• Cha MY, Ryu DK, Jung HS, et al. Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression. J Gen Virol 2009;90:978-86
   PubMed Web of Science ®Google Scholar
• Ma J, Sun T, Park S, et al. The role of hepatitis B virus X protein is related to its differential intracellular localization. Acta Biochim Biophys Sin 2011;43:583-8
   Google Scholar
• Wang Y, Lu Y, Toh ST, et al. Lethal-7 is down-regulatedbythe hepatitisBvirus x protein and targets signal transducer and activator of transcription 3. J Hepatol 2010;53:57-66
   PubMed Web of Science ®Google Scholar
• Qiu X, Dong S, Qiao F, et al. HBx-mediated miR-21 up-regulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene 2013;32:3296-305
   PubMed Web of Science ®Google Scholar
• Lankat-Buttgereit B, Goke R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 2009;101:309-17
   PubMed Web of Science ®Google Scholar
• Kong G, Zhang J, Zhang S, et al. Up-regulated miR-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 2011;6:19518
   PubMedGoogle Scholar
• Yuan K, Lian Z, Sun B, et al. Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One 2012;7:35331
   Web of Science ®Google Scholar
• Fujii R, Zhu C, Wen Y, et al. HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res 2006;66:9099-107
   PubMedGoogle Scholar
• Forgues M, Marrog AJ, Spillare EA, et al. Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway. J Biol Chem 2001;276:22797-803
   PubMedGoogle Scholar
• Forgues M, Difilippantonio MJ, Linke SP, et al. Involvement of Crm1 in hepatitis B virus X protein-induced centriole replication and abnormal mitotic spindles. Mol Cell Biol 2003;23:5282-92
   PubMedGoogle Scholar
• Matsuda Y, Ichida T. Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis. Med Mol Morphol 2009;42:138-42
   Web of Science ®Google Scholar
• Ueda H, Ullrich SJ, Gangemi JD, et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 1995;9:41-7
   PubMed Web of Science ®Google Scholar
• Mathonnet G, Lachance S, Alaoui-Jamali M, Drobetsky EA. Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells. Mutat Res 2004;554:305-18
   Google Scholar
• Wang XW, Gibson MK, Vermeulen W, et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995;55:6012-16
   PubMed Web of Science ®Google Scholar
• Becker SA, Lee TH, Butel JS, Slagle BL. Hepatitis B virus X protein interferes with cellular DNA repair. J Virol 1998;72:266-72
   PubMed Web of Science ®Google Scholar
• Jaitovich-Groisman I, Koshy R, Henkler F, et al. Down-regulation of DNA excision repair by the hepatitis B virus x protein occurs in p53 proficient and p53 deficient cells. Carcinogenesis 1999;20:479-83
   Google Scholar
• Oishi N, Shilagardi K, Nakamoto Y, et al. Hepatitis B virus X protein overcomes oncogenic RAS-induced senescence in human immortalized cells. Cancer Sci 2007;98:1540-8
   Google Scholar
• Lara-Pezzi E, Majano PL, Yáñez-Mó M, et al. Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J Hepatol 2001;34:409-15
   Google Scholar
• Zhang X, You X, Wang Q, et al. Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-kappaB, 5-LOX, OPN and Capn4 to promote cell migration. PLoS One 2012;7:e31458
   PubMed Web of Science ®Google Scholar
• Lara-Pezzi E, Serrador JM, Montoya MC, et al. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis. Hepatology 2001;33:1270-81
   Google Scholar
• Lara-Pezzi E, Gómez-Gaviro MV, Gálvez BG, et al. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 2002;110:1831-8
   Google Scholar
• Chung TW, Lee YC, Kim CH. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J 2004;18:1123-5
   PubMed Web of Science ®Google Scholar
• Yu FL, Liu HJ, Lee JW, et al. Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3. J Hepatol 2005;42:520-7
   Google Scholar
• Sze KM, Chu GK, Lee JM, Ng IO. C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 2013;57:131-9
   PubMed Web of Science ®Google Scholar
• Liu LP, Liang HF, Chen XP, et al. The role of NF-kappaB in Hepatitis B virus X protein-mediated up-regulation of VEGF and MMPs. Cancer Invest 2010;28:443-51
   PubMed Web of Science ®Google Scholar
• Raychaudhuri P, Park HJ. FoxM1: a master regulator of tumor metastasis. Cancer Res 2011;71:4329-33
   PubMed Web of Science ®Google Scholar
• Arzumanyan A, Sambandam V, Feitelson MA. Role of hedgehog signaling in the pathogenesis of hepatitis B associated hepatocellular carcinoma. Cancer Res 2012;72:5912-20
   PubMed Web of Science ®Google Scholar
• Klein NP, Schneider RJ. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol 1997;17:6427-36
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang J, You X, et al. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology 2012;56:2051-9
   PubMedGoogle Scholar
• Xia L, Huang W, Tian D, et al. Up-regulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. J Hepatol 2012;57:600-12
   PubMedGoogle Scholar
• Feitelson MA, Reis H, Liu J, et al. Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis. In: Zhao R, editor. Frontiers in bioscience. Viral Infect Cell Cycle Control 2005;10:1558-72
   Google Scholar
• Pang R, Lee TK, Poon RT, et al. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 2007;132:1088-103
   PubMedGoogle Scholar
• Theuerkorn M, Fischer G, Schiene-Fisher C. Prolyl cis/trans isomerase signaling pathways in cancer. Curr Opin Pharmacol 2011;11:281-7
   PubMed Web of Science ®Google Scholar
• Liou YC, Zhou XZ, Lu KP. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci 2011;36:501-14
   PubMed Web of Science ®Google Scholar
• Jung JK, Park SH, Jang KL. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by down-regulating retinoic acid receptor-beta2 expression via DNA methylation. J Gen Virol 2010;91:493-500
   PubMedGoogle Scholar
• Lian Z, Liu J, Li L, et al. Human S15a expression is up-regulated by hepatitis B virus X protein. Mol Carcinog 2004;40:34-46
   Google Scholar
• Lian Z, Pan J, Liu J, et al. The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene 1999;18:1677-87
   PubMedGoogle Scholar
• Feitelson MA. Parallel epigenetic and genetic changes in hepatitis B virus associated hepatocellular carcinoma. Cancer Lett 2006;239:10-20
   PubMed Web of Science ®Google Scholar